Gordon Zhang

Personal Highlights: • 13 Years working experience at Novartis: 10 years’ competitive intelligence working experience in NIBR Shanghai Operation (research part), almost 3 years’ experience in GDD China Operation (development part); • Pharmaceutical Competitive Intelligence Expert with rich experience, broad understanding of pharmaceutical industry from research, development, regulatory to commercial; • Gained global experience through more than 10 times Novartis internal mini-sabbatical and business travels to Basel, Boston, East Hanover, London & Singapore sites; • Mentor & Leader: Develop young talent through mentor relationship in Novartis; lead cross-functional projects through organization change; • Trainer & Facilitator: R&D CI Training; Artificial Intelligence lecture; Medical Information Excellence workshop; Strategy & Industry Trend seminar... • Chemistry Bachelor degree from Jilin University, 吉林大学化学本科 (2001); • BI-Fudan MBA Program, 复旦大学-BI挪威商学院MBA (Nov 2016-Jun 2019); Recent Projects but not limited to below ones: • Implement “Hospital Strategy Relationship” with Key China Hospitals through organizing a strategy committee; • Lead, organize or coordinate Novartis R&D internal projects, “Novartis round table meeting with KOL”, “Workshop for specific topic”, “Strategy Partnership Signing Ceremony”, “Novartis Next Generation Scientists Program” and “DIA sponsorship event” etc. • Provide intelligence support for NIBR Shanghai’s strategy not only from R&D Center strategy perspective but also from specific disease perspective, say Oncology, Liver, Regeneration medicine, cell and gene therapy landscape...; • External R&D projects scouting for BD; • Play a key role in Novartis Digital strategy on big data and AI’s application in R&D, delivered “Artificial Intelligence in Healthcare” talk to Novartis associates through Novartis Corporate University platform; • Enable all Novartis associates, from R&D, Medical Affair to Marketing to gain external Knowledge (Literature, Patent, Clinical Trials, Business News & Intelligence) through training; • Support building up “Medical Information Team” in 2019 as a critical advisor and trainer； • In charge of NIBR Shanghai's chemistry CRO (contract research organization) business in 2016.